-
Mashup Score: 3
Treatment paradigms may soon be shifting in head and neck cancer, as recent research indicates that lower doses of chemoradiotherapy may be appropriate for some patients.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 10
Phase 3 trial results on a precision radiotherapy technique support a ‘new gold standard’ for treating head and neck cancer patients. The research suggests the new approach can reduce the risk of swallowing problems after radiotherapy, without impacting the success of treatment.
Source: www.icr.ac.ukCategories: General Medicine News, Onc News and JournalsTweet-
📢NEWS: Advanced radiotherapy can reduce the risk of swallowing difficulties amongst patients receiving treatment for #HeadAndNeckCancer. New findings from a trial managed by the @ICR_CTSU and funded by @CR_UK were published in @TheLancetOncol. More here👇 https://t.co/PuHvaAHEoh
-
-
Mashup Score: 6
Phase 3 trial results on a precision radiotherapy technique support a ‘new gold standard’ for treating head and neck cancer patients. The research suggests the new approach can reduce the risk of swallowing problems after radiotherapy, without impacting the success of treatment.
Source: www.icr.ac.ukCategories: General Medicine News, Onc News and JournalsTweet-
📢NEWS: Advanced radiotherapy can reduce the risk of swallowing difficulties amongst patients receiving treatment for #HeadAndNeckCancer. New findings from a trial managed by the @ICR_CTSU and funded by @CR_UK were published in @TheLancetOncol. More here👇 https://t.co/PuHvaAHEoh
-
-
Mashup Score: 8EORTC's Presence At ESMO 2023 2023 - EORTC - 6 month(s) ago
New findings and upcoming EORTC trials in lung, head and neck, breast and rare cancers will be presented at ESMO 2023 in Madrid, highlighting EORTC’s
Source: www.eortc.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We are excited to share that we will present 7 abstracts on lung, head and neck, breast and rare cancers at #ESMO23 in Madrid. Learn more: https://t.co/IM2PDtSIOr @myESMO #CancerResearch #ClinicalTrials #BreastCancer #LungCancer #RareCancers #HeadAndNeckCancer https://t.co/Z2zGOREfCE
-
-
Mashup Score: 3
Jennifer Grandis, MD, is a surgeon-scientist who is anotolaryngologist and associate vice chancellor forclinical and translational research at UCSF. Sheis a …
Source: www.youtube.comCategories: Hem/Oncs, Latest HeadlinesTweet-
It was a joy hosting @UCSF’s @JenniferGrandis as she discussed #HeadAndNeckCancer translational medicine. Watch https://t.co/oEORRBULa7. Stay tuned for the forthcoming announcement of our distinguished 2024 speakers and schedule.
-
-
Mashup Score: 0Patient hails new UW Health dry mouth treatment a 'game-changer' - 6 month(s) ago
Dry mouth can cause dental and salivary gland concerns.
Source: spectrumnews1.comCategories: Latest Headlines, Oncologists1Tweet-
Congrats to @KimpleRandall @UW_RadoncDHO and @JacquesGalipeau @uw_hemeoncpc on manufacturing IFNg-licensed #MSCs as cell therapy for relieving dry mouth after radiation therapy in #headandneckcancer patients @UWCarbone @UWSCRMC https://t.co/qkIQiLqx8B
-
-
Mashup Score: 0
Immunotherapy can extend the response of some head and neck tumours to treatment, maintaining the anti-tumour effects and preventing them from growing or spreading for longer, a study reports.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📢NEWS: In patients whose #Cancers are sensitive to #Immunotherapy, the treatment can help to control tumour growth in #HeadAndNeckCancer and offer a kinder treatment, with fewer side effects than standard therapy. Read more 👇 https://t.co/r2H4grlh79
-
-
Mashup Score: 0EA3202 Home Page - ECOG-ACRIN Cancer Research Group - 7 month(s) ago
Patient must have histologically confirmed squamous cell carcinoma of the head and neck (HNSCC) (excluding SCC of salivary glands, Epstein-Barr virus [EBV]-associated nasopharynx and skin)Patient must have measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1. Measurements must be obtained within 4 weeks prior to randomizationPatient must be >= 18…
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ClinicalTrial EA3202, led by @AartiBhatiaMD of @YaleCancer, aims to improve results for patients with advanced-stage #HeadAndNeckCancer by comparing several treatment approaches. Learn more: https://t.co/IHBhEYp1Fo #HNCA #HNCASM https://t.co/SRxfYpuZ2Q
-
-
Mashup Score: 0
Matching cancer patients to treatment based on their levels of a key immune protein may allow doctors to select those who would benefit most from the combination of immunotherapy and chemotherapy, researchers report.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
This week is European #HeadAndNeckCancer Awareness Week. ICR scientists showed that #HeadAndNeckCancer patients benefited from different treatments depending on the results of a test measuring levels of of the protein PD-L1 in tumours. Read more⬇️ https://t.co/p2tx5vFfgg
-
-
Mashup Score: 0PET/CT Follow-Up May Confer Survival Benefit in Head and Neck Cancer - 8 month(s) ago
Annual follow-up with 18FDG-PET/CT may improve survival, as compared to conventional follow-up, in patients with head and neck cancer.
Source: www.oncologynurseadvisor.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Annual follow-up with 18FDG-PET/CT can improve survival, as compared to conventional follow-up, in patients with #headandNeckCancer. Published in @JAMANetworkOpen and @CancerTherAdvsr. https://t.co/xqW7J5h4Lk #HNCCancer
-
For patients with #headandneckcancer, a one-size-fits-all chemoradiotherapy treatment is not the best approach, according to an expert from @MSKCancerCenter. Read to Learn More: https://t.co/hVmM18aVL6